Chlorpropamide

ANDA 88175, held by Par Pharm. Chlorpropamide.

As of Nov 13, 2026, ANDA 88175 (Chlorpropamide), held by Par Pharm, was first approved by FDA on Feb 27, 1984, with 9 approved supplements and 0 published complete response letters.

First approved: Feb 27, 1984
Supplements approved: 9
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 10 submissions below

Date	Submission	Status	Documents
Feb 27, 1984	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Chlorpropamide100MG · tablet;oral	Chlorpropamide	Discontinued

All 10 submissions, including labeling and manufacturing supplements

Date	Submission	Status	Documents
Mar 10, 1986	Supplement 12Manufacturing	Approved	None posted
Feb 21, 1985	Supplement 9Manufacturing	Approved	None posted
Feb 21, 1985	Supplement 8Manufacturing	Approved	None posted
Sep 20, 1984	Supplement 6Manufacturing	Approved	None posted
Sep 20, 1984	Supplement 5Manufacturing	Approved	None posted
Sep 20, 1984	Supplement 4Manufacturing	Approved	None posted
Sep 20, 1984	Supplement 3Manufacturing	Approved	None posted
Sep 20, 1984	Supplement 2Manufacturing	Approved	None posted
Apr 12, 1984	Supplement 1Manufacturing	Approved	None posted
Feb 27, 1984	Original application	Approved	None posted

Identifiers

Application: ANDA 88175
Drugs@FDA: Overview at FDA
Company: Par Pharmaceutical

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters